Literature DB >> 11583957

Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers.

K L Woodford-Richens1, A J Rowan, R Poulsom, S Bevan, R Salovaara, L A Aaltonen, R S Houlston, N A Wright, I P Tomlinson.   

Abstract

Juvenile polyposis syndrome (JPS; OMIM 174900) is a rare disorder which is characterized by the presence of hamartomatous polyps throughout the gastrointestinal tract and an increased risk of gastrointestinal malignancy. Mutations of the SMAD4 gene on chromosome 18q21.1 have been shown to cause a subset of JPS cases, with estimates ranging from 20% to >50%. Characterization of the genes that cause the remainder of JPS cases relies on the certainty that SMAD4 is not the causative gene. We have undertaken a comprehensive analysis of germline SMAD4 mutations in a cohort of JPS patients to define the spectrum of mutations that cause JPS. We have analyzed a series of polyps from these patients for SMAD4 protein expression. We have also performed a blinded assessment of polyp material to look for morphological differences between polyps from patients with and without a germline SMAD4 mutation. The results indicate that almost all germline SMAD4 mutations are readily detectable by screening genomic DNA using polymerase chain reaction-based methods; SMAD4 can be excluded as the causative gene in the majority of our JPS cohort. Loss of SMAD4 expression occurs in most polyps from SMAD4 mutation carriers, even those with missense germline mutations. SMAD4 loss in polyps is, however, not a feature of cases that are not caused by SMAD4 mutations, indicating that these polyps develop along a SMAD4-independent pathway. The morphology of polyps from SMAD4 mutation carriers is subtly different from other JPS polyps, notably including a more prominent epithelial component in the former.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583957      PMCID: PMC1850516          DOI: 10.1016/S0002-9440(10)62516-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

Authors:  R E Wilentz; G H Su; J L Dai; A B Sparks; P Argani; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.

Authors:  K Takaku; H Miyoshi; A Matsunaga; M Oshima; N Sasaki; M M Taketo
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

3.  Juvenile polyposis coli.

Authors:  A M Veale; I McColl; H J Bussey; B C Morson
Journal:  J Med Genet       Date:  1966-03       Impact factor: 6.318

4.  Germline mutations of the dpc4 gene in Korean juvenile polyposis patients.

Authors:  I J Kim; J L Ku; K A Yoon; S C Heo; S Y Jeong; H S Choi; K H Hong; S K Yang; J G Park
Journal:  Int J Cancer       Date:  2000-05-15       Impact factor: 7.396

5.  Role of transforming growth factor-beta signaling in cancer.

Authors:  M P de Caestecker; E Piek; A B Roberts
Journal:  J Natl Cancer Inst       Date:  2000-09-06       Impact factor: 13.506

6.  Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4.

Authors:  A Morén; S Itoh; A Moustakas; P Dijke; C H Heldin
Journal:  Oncogene       Date:  2000-09-07       Impact factor: 9.867

7.  Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.

Authors:  J R Howe; J L Bair; M G Sayed; M E Anderson; F A Mitros; G M Petersen; V E Velculescu; G Traverso; B Vogelstein
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

8.  Analysis of genetic and phenotypic heterogeneity in juvenile polyposis.

Authors:  K Woodford-Richens; S Bevan; M Churchman; B Dowling; D Jones; C G Norbury; S V Hodgson; D Desai; K Neale; R K Phillips; J Young; B Leggett; M Dunlop; P Rozen; C Eng; D Markie; M A Rodriguez-Bigas; E Sheridan; T Iwama; D Eccles; G T Smith; J C Kim; K M Kim; J R Sampson; G Evans; S Tejpar; W F Bodmer; I P Tomlinson; R S Houlston
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

9.  Homozygous deletion map at 18q21.1 in pancreatic cancer.

Authors:  S A Hahn; A T Hoque; C A Moskaluk; L T da Costa; M Schutte; E Rozenblum; A B Seymour; C L Weinstein; C J Yeo; R H Hruban; S E Kern
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

10.  Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium.

Authors:  K Woodford-Richens; J Williamson; S Bevan; J Young; B Leggett; I Frayling; Y Thway; S Hodgson; J C Kim; T Iwama; M Novelli; D Sheer; R Poulsom; N Wright; R Houlston; I Tomlinson
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

View more
  17 in total

1.  Mutation screening in juvenile polyposis syndrome.

Authors:  Robert E Pyatt; Robert Pilarski; Thomas W Prior
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

Review 2.  Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir.

Authors:  Aga Syed Sameer
Journal:  Tumour Biol       Date:  2013-02-17

3.  Histologic variations in juvenile polyp phenotype correlate with genetic defect underlying juvenile polyposis.

Authors:  Willem Arnout van Hattem; Danielle Langeveld; Wendy W J de Leng; Folkert H Morsink; Paul J van Diest; Christine A Iacobuzio-Donahue; Francis M Giardiello; G Johan A Offerhaus; Lodewijk A A Brosens
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

Review 4.  Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.

Authors:  Henry T Lynch; Jane F Lynch; Patrick M Lynch; Thomas Attard
Journal:  Fam Cancer       Date:  2007-11-13       Impact factor: 2.375

Review 5.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

6.  SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene.

Authors:  A Syed Sameer; Nissar A Chowdri; Nidda Syeed; Mujeeb Z Banday; Zaffar A Shah; Mushtaq A Siddiqi
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

Review 7.  Genetics of the hamartomatous polyposis syndromes: a molecular review.

Authors:  Hui-Min Chen; Jing-Yuan Fang
Journal:  Int J Colorectal Dis       Date:  2009-04-21       Impact factor: 2.571

8.  Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.

Authors:  Hye Jung Baek; Sung Chul Lim; Krit Kitisin; Wilma Jogunoori; Yi Tang; M Blair Marshall; Bibhuti Mishra; Tae Hyun Kim; Kwan Ho Cho; Sang Soo Kim; Lopa Mishra
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

9.  An audit of familial juvenile polyposis at the Tel Aviv Medical Center: demographic, genetic and clinical features.

Authors:  Paul Rozen; Ziona Samuel; Eli Brazowski; Markus Jakubowicz; Jacob Rattan; Zamir Halpern
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

Review 10.  Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Authors:  Gulcin Tezcan; Berrin Tunca; Secil Ak; Gulsah Cecener; Unal Egeli
Journal:  World J Gastrointest Oncol       Date:  2016-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.